-
1
-
-
14944385553
-
Global cancer statistics 2002
-
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
-
(2005)
CA Cancer J Clin
, vol.55
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
2
-
-
2442595906
-
The economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: Findings from a retrospective analysis of health plan data
-
DOI 10.1097/01.ju.0000127732.63726.4c
-
Penson DF, Moul JW, Evans CP, et al. The economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: findings from a retrospective analysis of health plan data. J Urol, 2004;171(6 Pt 1):2250-4. (Pubitemid 38625445)
-
(2004)
Journal of Urology
, vol.171
, Issue.6 I
, pp. 2250-2254
-
-
Penson, D.F.1
Moul, J.W.2
Evans, C.P.3
Doyle, J.J.4
Gandhi, S.5
Lamerato, L.6
-
3
-
-
3342971378
-
Cost of managing women presenting with stage IV breast cancer in the United Kingdom
-
DOI 10.1038/sj.bjc.6601890
-
Remak E, Brazil L. Cost of managing women presenting with stage IV breast cancer in the United Kingdom. Br J Cancer 2004;91:77-83. (Pubitemid 39013048)
-
(2004)
British Journal of Cancer
, vol.91
, Issue.1
, pp. 77-83
-
-
Remak, E.1
Brazil, L.2
-
4
-
-
0034112462
-
Estimates of the lifetime costs of breast cancer treatment in Canada
-
DOI 10.1016/S0959-8049(99)00340-8, PII S0959804999003408
-
Will BP, Berthelot JM, Le Petit C, et al. Estimates of the lifetime costs of breast cancer treatment in Canada. Eur J Cancer 2000;36:724-35. (Pubitemid 30179743)
-
(2000)
European Journal of Cancer
, vol.36
, Issue.6
, pp. 724-735
-
-
Will, B.P.1
Berthelot, J.-M.2
Le Petit, C.3
Tomiak, E.M.4
Verma, S.5
Evans, W.K.6
-
5
-
-
85031214859
-
-
Direcção-Geral da Saúde, [Accessed August 27, 2009]
-
Direcção-Geral da Saúde. Risco de Morrer em Portugal 2005. Volume II. 2008. Available from: http://www.dgs.pt [Accessed August 27, 2009].
-
(2008)
Risco de Morrer em Portugal 2005
, vol.2
-
-
-
6
-
-
0030749321
-
Skeletal complications of malignancy
-
Coleman RE. Skeletal complications of malignancy. Cancer 1997;80(8 Suppl):1588-94. (Pubitemid 27444031)
-
(1997)
Cancer
, vol.80
, Issue.8 SUPPL.
, pp. 1588-1594
-
-
Coleman, R.E.1
-
7
-
-
3242772959
-
Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy
-
DOI 10.1002/cncr.20388
-
Krupski TL, Smith MR, Lee WC, et al. Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Cancer 2004;101:541-9. (Pubitemid 38970605)
-
(2004)
Cancer
, vol.101
, Issue.3
, pp. 541-549
-
-
Krupski, T.L.1
Smith, M.R.2
Lee, W.C.3
Pashos, C.L.4
Brandman, J.5
Wang, Q.6
Botteman, M.7
Litwin, M.S.8
-
8
-
-
33746969954
-
Clinical management of women with metastatic breast cancer: A descriptive study according to age group
-
Manders K, van de Poll-Franse LV, Creemers GJ, et al. Clinical management of women with metastatic breast cancer: a descriptive study according to age group. BMC Cancer 2006;6:179.
-
(2006)
BMC Cancer
, vol.6
, pp. 179
-
-
Manders, K.1
Van De Poll-Franse, L.V.2
Creemers, G.J.3
-
9
-
-
18144427879
-
The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer
-
DOI 10.1093/annonc/mdi122
-
Weinfurt KP, Li Y, Castel LD, et al. The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer. Ann Oncol 2005;16:579-84. (Pubitemid 40613323)
-
(2005)
Annals of Oncology
, vol.16
, Issue.4
, pp. 579-584
-
-
Weinfurt, K.P.1
Li, Y.2
Castel, L.D.3
Saad, F.4
Timbie, J.W.5
Glendenning, G.A.6
Schulman, K.A.7
-
10
-
-
35048875471
-
Pathologic fractures correlate with reduced survival in patients with malignant bone disease
-
DOI 10.1002/cncr.22991
-
Saad F, Lipton A, Cook R, et al. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer 2007;110:1860-7. (Pubitemid 47557312)
-
(2007)
Cancer
, vol.110
, Issue.8
, pp. 1860-1867
-
-
Saad, F.1
Lipton, A.2
Cook, R.3
Chen, Y.-M.4
Smith, M.5
Coleman, R.6
-
11
-
-
34548584066
-
Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer
-
DOI 10.1007/s00520-006-0203-x
-
DePuy V, Anstrom KJ, Castel LD, et al. Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer. Support Care Cancer 2007;15:869-76. (Pubitemid 47387507)
-
(2007)
Supportive Care in Cancer
, vol.15
, Issue.7
, pp. 869-876
-
-
DePuy, V.1
Anstrom, K.J.2
Castel, L.D.3
Schulman, K.A.4
Weinfurt, K.P.5
Saad, F.6
-
12
-
-
36649001116
-
Bisphosphonates: Reducing the risk of skeletal complications from bone metastasis
-
Costa L. Bisphosphonates: reducing the risk of skeletal complications from bone metastasis. Breast 2007;16(Suppl. 3):S16 -20.
-
(2007)
Breast
, vol.16
, Issue.SUPPL. 3
-
-
Costa, L.1
-
13
-
-
0027481724
-
Advanced breast cancer: Use of resources and cost implications
-
Richards MA, Braysher S, Gregory WM, Rubens RD. Advanced breast cancer: use of resources and cost implications. Br J Cancer 1993;67:856-60. (Pubitemid 23101574)
-
(1993)
British Journal of Cancer
, vol.67
, Issue.4
, pp. 856-860
-
-
Richards, M.A.1
Braysher, S.2
Gregory, W.M.3
Rubens, R.D.4
-
14
-
-
0242669907
-
Costs of prostate cancer, metastatic to the bone, in The Netherlands
-
DOI 10.1016/S0302-2838(03)00007-1
-
Groot MT, Boeken Kruger CG, Pelger RC, Uyl-de Groot CA. Costs of prostate cancer, metastatic to the bone, in the Netherlands. Eur Urol 2003;43:226-32. (Pubitemid 36314233)
-
(2003)
European Urology
, vol.43
, Issue.3
, pp. 226-232
-
-
Groot, M.T.1
Kruger, C.G.G.B.2
Pelger, R.C.M.3
Uyl-de Groot, C.A.4
-
15
-
-
33748871114
-
Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice
-
Delea T, McKiernan J, Brandman J, et al. Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. J Support Oncol 2006;4:341-7. (Pubitemid 44420137)
-
(2006)
Journal of Supportive Oncology
, vol.4
, Issue.7
, pp. 341-347
-
-
Delea, T.1
McKiernan, J.2
Brandman, J.3
Edelsberg, J.4
Sung, J.5
Raut, M.6
Oster, G.7
-
16
-
-
43949146650
-
The cost of treating skeletalrelated events in patients with prostate cancer
-
Lage MJ, Barber BL, Harrison DJ, Jun S. The cost of treating skeletalrelated events in patients with prostate cancer. Am J Manag Care 2008; 14:317-22.
-
(2008)
Am J Manag Care
, vol.14
, pp. 317-322
-
-
Lage, M.J.1
Barber, B.L.2
Harrison, D.J.3
Jun, S.4
-
17
-
-
1442351128
-
A systematic review of the role of bisphosphonates in metastatic disease
-
Ross JR, Saunders Y, Edmonds PM, Patel S, et al. A systematic review of the role of bisphosphonates in metastatic disease. Health Technol Assess 2004;8:1-176.
-
(2004)
Health Technol Assess
, vol.8
, pp. 1-176
-
-
Ross, J.R.1
Saunders, Y.2
Edmonds, P.M.3
Patel, S.4
-
18
-
-
85031232477
-
-
Ministério da Saúde and Instituto de Gestão Informática e Financeira da Saúde, [Accessed March 22 2010]
-
Ministério da Saúde and Instituto de Gestão Informática e Financeira da Saúde. Estatísticas do movimento assistencial 2002-2005. Available from: www.igif.min-saude.pt [Accessed March 22, 2010].
-
Estatísticas do movimento assistencial 2002-2005
-
-
-
19
-
-
85031220639
-
-
Ministério da Saúde. Portaria no132/2003 de 5 de Fevereiro. Diário da República I série B. 2003
-
Ministério da Saúde. Portaria no132/2003 de 5 de Fevereiro. Diário da República I série B. 2003.
-
-
-
-
21
-
-
5344244656
-
-
R Development Core Team. R Foundation for Statistical Computing Vienna Austria, [Accessed March 22 2010]
-
R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2008 Available from: http://www.R-project.org [Accessed March 22, 2010].
-
(2008)
R: A Language and Environment for Statistical Computing
-
-
-
22
-
-
0034008718
-
Economic analysis of terminal care for patients with malignant osteolytic bone disease and pain treated with pamidronate
-
Gessner U, Koeberle D, Thuerlimann B, et al. Economic analysis of terminal care for patients with malignant osteolytic bone disease and pain treated with pamidronate. Support Care Cancer 2000;8:115-22. (Pubitemid 30114819)
-
(2000)
Supportive Care in Cancer
, vol.8
, Issue.2
, pp. 115-122
-
-
Gessner, U.1
Koeberle, D.2
Thuerlimann, B.3
Bacchus, L.4
Horisberger, B.5
-
23
-
-
53149089426
-
Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases: Analysis of a national medical claims database
-
Hatoum HT, Lin SJ, Smith MR, et al. Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases: analysis of a national medical claims database. Cancer 2008;113:1438-45.
-
(2008)
Cancer
, vol.113
, pp. 1438-1445
-
-
Hatoum, H.T.1
Lin, S.J.2
Smith, M.R.3
-
24
-
-
10744233021
-
Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: A randomized, double-blind, multicenter, comparative trial
-
DOI 10.1002/cncr.11701
-
Rosen LS, Gordon D, Kaminski M, et al. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer 2003;98:1735-44. (Pubitemid 37238631)
-
(2003)
Cancer
, vol.98
, Issue.8
, pp. 1735-1744
-
-
Rosen, L.S.1
Gordon, D.2
Kaminski, M.3
Howell, A.4
Belch, A.5
Mackey, J.6
Apffelstaedt, J.7
Hussein, M.A.8
Coleman, R.E.9
Reitsma, D.J.10
Chen, B.-L.11
Seaman, J.J.12
-
26
-
-
18844440666
-
Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK
-
DOI 10.1185/030079905X40472
-
Guest JF, Clegg JP, Davie AM, McCloskey E. Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK. Curr Med Res Opin 2005;21:805-15. (Pubitemid 40695303)
-
(2005)
Current Medical Research and Opinion
, vol.21
, Issue.5
, pp. 805-815
-
-
Guest, J.F.1
Clegg, J.P.2
Davie, A.M.3
McCloskey, E.4
-
27
-
-
66949136282
-
Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: A meta-analysis of randomized clinical trials
-
Machado M, Cruz LS, Tannus G, Fonseca M. Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials. Clin Ther 2009;31:962-79.
-
(2009)
Clin Ther
, vol.31
, pp. 962-979
-
-
Machado, M.1
Cruz, L.S.2
Tannus, G.3
Fonseca, M.4
-
28
-
-
45149127283
-
Cost-effectiveness of oral clodronate compared with oral ibandronate, intravenous zoledronate or intravenous pamidronate in breast cancer patients
-
Paterson A, McCloskey E, Redzepovic J, Ott I, Gust R. Cost-effectiveness of oral clodronate compared with oral ibandronate, intravenous zoledronate or intravenous pamidronate in breast cancer patients. J Int Med Res 2008; 36:400-13. (Pubitemid 351833589)
-
(2008)
Journal of International Medical Research
, vol.36
, Issue.3
, pp. 400-413
-
-
Paterson, A.H.G.1
McCloskey, E.2
Redzepovic, J.3
Ott, I.4
Gust, R.5
-
29
-
-
13444256141
-
Zoledronic acid versus pamidronate: Cost minimisation in bone metastasis
-
Slof J, Badia X, Lizán L, et al. Zoledronic acid versus pamidronate: cost minimisation in bone metastasis. J Med Econ 2005;8:1-12. (Pubitemid 40216027)
-
(2005)
Journal of Medical Economics
, vol.8
, Issue.1-12
, pp. 1-12
-
-
Slof, J.1
Badia, X.2
Lizan, L.3
Bautista, F.J.4
Echarri, E.5
Hurle, A.D.G.6
Pla, R.7
Mangues, M.A.8
Rodriguez-Sasiain, J.-M.9
Wood, M.A.10
-
30
-
-
36549012194
-
Higher persistency with i.v. bisphosphonates in patients with bone metastasis
-
abstract 18623
-
Mangiapane S, Hoer A, Gothe H, et al. Higher persistency with i.v. bisphosphonates in patients with bone metastasis. J Clin Oncol 2006; 24(18 Suppl.):698s [abstract 18623].
-
(2006)
J Clin Oncol
, vol.24
, Issue.18 SUPPL.
-
-
Mangiapane, S.1
Hoer, A.2
Gothe, H.3
-
31
-
-
0344309882
-
Hospital bed utilisation in the NHS, Kaiser Permanente, and the US Medicare programme: Analysis of routine data
-
Ham C, York N, Sutch S, Shaw R. Hospital bed utilisation in the NHS, Kaiser Permanente, and the US Medicare programme: analysis of routine data. BMJ 2003;327:1257.
-
(2003)
BMJ
, vol.327
, pp. 1257
-
-
Ham, C.1
York, N.2
Sutch, S.3
Shaw, R.4
-
32
-
-
37249057002
-
Trends in hospital bed utilisation in New Zealand 1989 to 2006: More or less beds in the future?
-
Malcolm L. Trends in hospital bed utilisation in New Zealand 1989 to 2006: more or less beds in the future? N Z Med J 2007;120:U2772.
-
(2007)
N Z Med J
, vol.120
-
-
Malcolm, L.1
-
33
-
-
1642571450
-
-
Organization for Economic Co-operation and Development, [Accessed June 18, 2009]
-
Organization for Economic Co-operation and Development. Health at a glance 2007: OECD indicators. Available from: http://www.oecd.org [Accessed June 18, 2009].
-
Health at A Glance 2007: OECD Indicators
-
-
-
34
-
-
0036676214
-
Estimating health care costs related to cancer treatment from SEER-Medicare data
-
Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care 2002;40(8 Suppl):IV-104-17.
-
(2002)
Med Care
, vol.40
, Issue.8 SUPPL.
-
-
Brown, M.L.1
Riley, G.F.2
Schussler, N.3
Etzioni, R.4
-
35
-
-
1542723219
-
A longitudinal study of the effects of age and time to death on hospital costs
-
DOI 10.1016/j.jhealeco.2003.08.004, PII S0167629603000857
-
Seshamani M, Gray AM. A longitudinal study of the effects of age an time to death on hospital costs. J Health Econ 2004;23:217-35. (Pubitemid 38333024)
-
(2004)
Journal of Health Economics
, vol.23
, Issue.2
, pp. 217-235
-
-
Seshamani, M.1
Gray, A.M.2
-
36
-
-
33746853119
-
Health care costs in the last year of life-The Dutch experience
-
DOI 10.1016/j.socscimed.2006.04.018, PII S0277953606002279
-
Polder JJ, Barendregt JJ, van Oers V. Health care costs in the last year of life - the Dutch experience. Soc Sci Med 2006;63:1720-31. (Pubitemid 44176177)
-
(2006)
Social Science and Medicine
, vol.63
, Issue.7
, pp. 1720-1731
-
-
Polder, J.J.1
Barendregt, J.J.2
Van Oers, H.3
-
37
-
-
0030919507
-
Economic foundations of cost-effectiveness analysis
-
DOI 10.1016/S0167-6296(96)00506-1, PII S0167629696005061
-
Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ 1997;16:1-31. (Pubitemid 27224092)
-
(1997)
Journal of Health Economics
, vol.16
, Issue.1
, pp. 1-31
-
-
Garber, A.M.1
Phelps, C.E.2
|